Supply of Erythropoietin Stimulating Agents
NHS Framework Agreement for the supply of Erythropoietin Stimulating Agents to the East of England Purchasing Group. The Secretary of State for Health. UK-Reading: various medicinal products
Section I: Contracting authority
The Secretary of State for Health acting through the Commercial Medicines Unit (part of the Department of Health)
Premier House, 60 Caversham Road
For the attention of: Sarah Blackman
RG1 7EB Reading
General address of the contracting authority: https://cmu.bravosolution.co.uk
Further information can be obtained from: The above mentioned contact point(s)
Specifications and additional documents (including documents for competitive dialogue and a dynamic purchasing system) can be obtained from: The above mentioned contact point(s)
Tenders or requests to participate must be sent to: The above mentioned contact point(s)
Other: Public Procurement
Section II: Object of the contract
Main site or location of works, place of delivery or of performance: Document 10a of the ITT Documents.
NUTS code UK
Duration of the framework agreement
Duration in years: 2
Offer reference number: CM/PHR/10/5197.
Period of framework: 1st November 2012 to 31st October 2014 with option to extend up to an additional 24 months.
33690000, 33693000, 85149000, 33000000
Description of these options: 24 month option to extend.
Section III: Legal, economic, financial and technical information
1) Entering general ITT supplier information
The CMU (part of the Department of Health) utilizes the NHS Supplier Information Database (sid4health) to manage and assess general pre-qualification information in the form of a profile. Candidates are requested to provide their profile in sid4health as follows:
i) Candidates must obtain a Dun & Bradstreet (D&B) D-U-N-S® Number to enable registration on sid4health. This normally is provided within 48 hours but may take up to 5 days*, so please ensure this step is completed as soon as possible. The D-U-N-S® number is the standard supplier coding for the NHS and must be obtained for use in all trading with the NHS. Check to see if your company has a D-U-N-S® Number on the Sid4health registration page.
* The D-U-N-S® Number registration turnaround time quoted is for UK subjects. Non UK subjects (businesses registered outside of the UK), should use www.dnb.com and choose the country in which the business is registered from the selection at the top of the Home page and then search for DUNS request form. If unable to find a DUNS request form please contact the local Customer Services team. Turnaround times will vary from Country to country.
ii) Candidates must go to the following web page http://www.sid4health.nhs.uk/home.action. Select the Register Organisation on the left of the page and then select Organisation Type supplier. Key in details as shown to search for your D-U-N-S® Number. If you are not on their database click on the link at the bottom of the page to obtain a number from D&B.
iii) Once registration has been authorised by the sid4health administrator and after receiving logon details, access the Profile Management area and create and validate your sid4health company profile. (Candidates must publish at least one validated profile to make their profile available for buyers to view generally – see the Help page on sid4health within Profile Management for more details).
iv) Candidates should ensure all the mandatory fields of their sid4health profile are completed. Failure to comply with the completion of all mandatory fields could result in the elimination from the procurement process at this ITT stage. D&B data will be supplied automatically by D&B. (notes 1, through to 5 below refer)
v) Once a candidate has ensured that all the required fields are completed for this ITT and the profile has been validated. They must add the profile to the Request to Participate list ID’d (T1200-263) and named itt_29421 East of England Erythropoietin Stimulating Agents. Select ‘View all request to participate lists’ on the left menu and search/select this list. Select the Join button to the right of the list and then select the validated profile to allocate to this procurement (you may have more than one validated profile as you may have different information held against your profile for different procurements)
(vi) Where access to Sid4health is unavailable, please contact the sid4health Helpdesk at: firstname.lastname@example.org
2) submission of expression of interest and procurement specific information
This procurement exercise will be conducted on the CMU (part of the Department of Health) eTendering portal at www.cmu.bravosolution.co.uk. Candidates wishing to be considered for this contract must register their expression of interest and provide additional procurement specific information (if required) through the CMU (part of the Department of Health) eTendering portal as follows:
i) Candidates should register on the CMU (part of the Department of Health) eTendering portal at https://www.cmu.bravosolution.co.uk and click the link to register:
— Accept the terms and conditions and click continue,
— Enter your correct business and user details,
— Note the username you chose and click save when complete,
— You will shortly receive an email with your unique password (please keep this secure).
ii) Once registered, candidates must express your interest as follows:
a. login to the CMU (part of the Department of Health) eTendering portal
b. select Response to ITT
c. select ITTs Open To All Suppliers
d. access listing related to this contract itt_29421 titled East of England Erythropoietin Stimulating Agents and view details
e. click on express interest button in the actions box on the left-hand side of the page.
iii) Once you have expressed interest, the ITT will move to My ITTs, where you can download additional documentation (if required in III.2.1.1.ii above), and construct your reply as instructed. You must then publish your reply using the publish button.
iv) For any support in submitting your expression of interest please contact the ETendering Help-desk at +44 800 368 4850 or email@example.com.
Section IV: Procedure
Section VI: Complementary information
The contract is for the benefit of other participating NHS bodies (whether acting individually, or on behalf of, or together as members of any consortia) along with any other non-NHS bodies which the participants deem necessary for the delivery of services or goods to NHS bodies, local authorities, other government departments or non-departmental public bodies charged with the delivery of healthcare or health related services.
Contracts awarded under a framework agreement may be awarded either:
a) by application of the terms laid down in the framework agreement without reopening competition, or
b) where not all the required terms of the proposed contracts are laid down in the framework agreement, by reopening competition between the economic operators which are parties to this framework agreement and which are capable of performing the proposed contract. Reopening of competition will be done in accordance with the procedure set out in Directive 2004/18/EC, Article 32.
The operation of the framework agreement will incorporate the reopening of competition between the economic operators which are party to the framework agreement so as to incorporate the effects of competition, and the effect on competition, derived from beneficiaries of and parties to the contracts under the Agreement to include central purchasing bodies as detailed in Article 32 of Directive 2004/18/EC; Collaborative Purchasing Hubs; Confederations; Purchasing Consortiums; Trusts and other incorporated and un-incorporated bodies acting under the aegis of aggregate purchasing policies, and/or volume commitment/exclusivity commitment policies, and forms devolved to regional and local levels within the UK National Health Service (NHS).
Potential suppliers should note that, in accordance with the Government’s policies on transparency, the CMU (part of the Department of Health) intends to publish the Invitation to Tender (ITT) document, and the text of any Framework Agreement awarded, subject to possible redactions at the discretion of the CMU (part of the Department of Health). The terms of the proposed Framework Agreement will also permit a public sector contracting authority, awarding a contract under this Framework Agreement, to publish the text of that contract, subject to possible redactions at the discretion of the contracting authority. Further information on transparency can be found at http://www.ogc.gov.uk/policy and standards framework transparency.asp.
The Contracting Authority will incorporate a standstill period at the point the decision regarding the award of the contract is communicated to Offerors. The Contracting Authority draws Offerors attention to their rights under the Public Contracts Regulations 2006 as amended by the Public Contracts (Amendment) Regulations 2009.
VI.5)Date of dispatch of this notice:1.6.2012